Home > Legal Library > Advanced Search > Search Results









Join Matindale-Hubbell Connected



Loeb & Loeb LLP Document Search Results (127)

 

View Page: 1  2  3  4  5  6  7  8  9  10  Next  >>
Show: results per page
Sort by:
Sponsored Results

HTMLRetail Tracking Firm Slammed with FTC Consent Order
Kenneth R. Florin, Ieuan Jolly, David G. Mallen, James D. Taylor; Loeb & Loeb LLP;
Legal Alert/Article
May 19, 2015, previously published on May 2015
The Federal Trade Commission last month announced a proposed consent order settling claims against Nomi Technologies, a third-party mobile tracking service that collects data about consumers' in-store shopping behavior. The FTC's case against Nomi is significant, but not for involving a...

 

HTMLOPDP to Study The Impact of Comparative Pricing Information in DTC and Professional Prescription Ads
Scott S. Liebman; Loeb & Loeb LLP;
Legal Alert/Article
May 15, 2015, previously published on April 2015
The agency will investigate how prescription drug product perceptions are impacted by the inclusion of price comparison information and supplementary contextual information in advertising geared at consumers and health care professionals, amid concern that the impression remains that price is the...

 

HTMLFDA Rejects Otsuka’s Assertions of Orphan Exclusivity for Abilify, Allowing Generics to Proceed
Scott S. Liebman; Loeb & Loeb LLP;
Legal Alert/Article
May 15, 2015, previously published on April 2015
The impact of the FDA’s decision is that several companies will be allowed to enter the market with generic aripiprazole, although the generics must carve out the use of the drug for treating pediatric Tourette’s Disorder from their labeling and marketing while the exclusivity period...

 

HTMLGuidance Explains How The FDA Will Define and Process Submissions for Changes to Risk Management Plans
Scott S. Liebman; Loeb & Loeb LLP;
Legal Alert/Article
May 15, 2015, previously published on April 2015
The regulator issued guidance on changes to approved risk evaluation and mitigation strategies (REMS), distinguishing “modifications” from “revisions,” and explaining how these should be submitted and how the FDA will review and act on them.

 

HTMLFDA Issues Guidance Documents on How It Considers Balancing Premarket and Postmarket Data Collection During PMA Reviews in a Bid to Accelerate the Approval of New Breakthrough Devices
Scott S. Liebman; Loeb & Loeb LLP;
Legal Alert/Article
May 15, 2015, previously published on April 2015
The regulator explains how it determines when it’s appropriate to increase reliance on postmarket collection to reduce the extent of premarket collection to support premarket approval, in a document integral to the CDRH’s risk-based approach to regulation and the FDA’s broader...

 

HTMLMorawski v. Lightstorm Entertainment, Inc.
Loeb Loeb LLP;
Legal Alert/Article
May 14, 2015, previously published on April 15, 2015
Ninth Circuit panel summarily affirms award of summary judgment in favor of James Cameron and Lightstorm Entertainment, rejecting plaintiff’s claims of breach of express contract, breach of implied-in-fact contract and fraud, where Cameron had presented detailed and copious evidence of...

 

HTMLFDA to Conduct Study to Determine Whether Medical Device Labeling Should Be Standardized
Scott S. Liebman; Loeb & Loeb LLP;
Legal Alert/Article
May 14, 2015, previously published on April 2015
The study will look into whether a standard format of labeling would be beneficial to healthcare providers, as the regulator worries current labeling is too complicated and difficult to navigate.

 

HTMLWilson v. The Walt Disney Company
Loeb Loeb LLP;
Legal Alert/Article
May 14, 2015, previously published on April 16, 2015
In copyright infringement action concerning trailer for Disney’s blockbuster film Frozen court denied both parties’ motions for summary judgment, finding that plaintiff established genuine factual dispute as to Disney’s access to her film.

 

HTMLFDA Rejects Otsuka’s Assertions of Orphan Drug Exclusivity for Abilify®, Allowing Generics to Proceed
Scott S. Liebman, Mark E. Waddell; Loeb & Loeb LLP;
Legal Alert/Article
May 7, 2015, previously published on May 1, 2015
The FDA last week granted several pharmaceutical companies approval to market generic versions of the bestselling antipsychotic drug Abilify® (aripiprazole), despite the assertions of the drug’s patent-holder, the Japanese pharmaceutical company Otsuka, that the company remained entitled...

 

HTMLRay v. ESPN, Inc.
Loeb Loeb LLP;
Legal Alert/Article
May 7, 2015
Eighth Circuit affirms dismissal of professional wrestler’s state-law right of publicity claims arising from ESPN’s re-telecast of wrestling match footage as preempted by Copyright Act.

 


View Page: 1  2  3  4  5  6  7  8  9  10  Next  >>